Compugen Ltd. Stock
Compugen Ltd. Stock price
Key metrics
| Market capitalization | $131.85m |
| Enterprise Value | $31.50m |
| P/E (TTM) P/E ratio | negative |
| EV/Sales (TTM) EV/Sales | 1.13 |
| P/S ratio (TTM) P/S ratio | 4.73 |
| P/B ratio (TTM) P/B ratio | 2.30 |
| Revenue growth (TTM) Revenue growth | -16.72% |
| Revenue (TTM) Revenue | $27.86m |
| EBIT (operating result TTM) EBIT | $-14.89m |
Is Compugen Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.
Compugen Ltd. Stock Analysis
Analyst Opinions
4 Analysts have issued a Compugen Ltd. forecast:
Analyst Opinions
4 Analysts have issued a Compugen Ltd. forecast:
Financial data from Compugen Ltd.
| Dec '24 |
+/-
%
|
||
| Revenue | 28 28 |
17%
17%
|
|
| Gross Profit | 20 20 |
37%
37%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -15 -15 |
15%
15%
|
| Net Profit | -14 -14 |
24%
24%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Compugen Ltd. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Compugen Ltd. Stock News
Company Profile
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
| Head office | Israel |
| CEO | Anat Cohen-Dayag |
| Employees | 74 |
| Founded | 1993 |
| Website | www.cgen.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
